4.82
price up icon5.24%   0.24
pre-market  Pre-mercato:  4.84   0.02   +0.41%
loading

Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie

pulisher
Apr 05, 2026

Panic Selling: Should I set a stop loss on Abeona Therapeutics Inc2026 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 03, 2026

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - sahmcapital.com

Apr 03, 2026
pulisher
Apr 02, 2026

ABEO PE Ratio & Valuation, Is ABEO Overvalued - Intellectia AI

Apr 02, 2026
pulisher
Apr 02, 2026

New York hospital joins Abeona network for blistering skin therapy - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

ABEO Should I Buy - Intellectia AI

Apr 02, 2026
pulisher
Apr 01, 2026

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 earnings call transcript - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

ABEO Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026
pulisher
Apr 01, 2026

Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona The - GuruFocus

Apr 01, 2026
pulisher
Mar 31, 2026

Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock - Investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Abeona (ABEO) CEO sells 29,985 shares under Rule 10b5-1 plan - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

ABEO (NASDAQ: ABEO) Form 144: 29,985 restricted shares proposed sale - Stock Titan

Mar 31, 2026
pulisher
Mar 27, 2026

Daniel Kaufman files Schedule 13G — Abeona (NASDAQ: ABEO) 5.16% stake - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

Vanguard disaggregates holdings; ABEO ownership shown as 0 (ABEO) - Stock Titan

Mar 26, 2026
pulisher
Mar 24, 2026

Meme Stocks: Does Abeona Therapeutics Inc have strong EBITDA margins2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Mar 24, 2026
pulisher
Mar 23, 2026

HC Wainwright Issues Pessimistic Outlook for ABEO Earnings - MarketBeat

Mar 23, 2026
pulisher
Mar 22, 2026

Oppenheimer Maintains Outperform on Abeona Therapeutics (ABEO) PT $22 March 2026 - Meyka

Mar 22, 2026
pulisher
Mar 21, 2026

Abeona Therapeutics Adopts Third Amended and Restated Bylaws Effective March 16, 2026 - Minichart

Mar 21, 2026
pulisher
Mar 20, 2026

Form 8K Abeona Therapeutics Inc For: 20 March By Investing.com - Investing.com Australia

Mar 20, 2026
pulisher
Mar 20, 2026

Form 8K Abeona Therapeutics Inc For: 20 March - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules - TipRanks

Mar 20, 2026
pulisher
Mar 20, 2026

Abeona (NASDAQ: ABEO) tightens bylaws on meetings and director nominations - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

Abeona Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 20, 2026
pulisher
Mar 19, 2026

Abeona Therapeutics Earnings Notes - Trefis

Mar 19, 2026
pulisher
Mar 19, 2026

Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB - Seeking Alpha

Mar 19, 2026
pulisher
Mar 19, 2026

HC Wainwright & Co. Reiterates Buy Rating for Abeona Therapeutics (ABEO) | ABEO Stock News - GuruFocus

Mar 19, 2026
pulisher
Mar 19, 2026

Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

Abeona Therapeutics (ABEO) Receives a Buy from Oppenheimer - The Globe and Mail

Mar 19, 2026
pulisher
Mar 19, 2026

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 19, 2026
pulisher
Mar 18, 2026

Abeona Therapeutics Balances Big Windfall With Slow Ramp - The Globe and Mail

Mar 18, 2026
pulisher
Mar 18, 2026

Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point (NASDAQ:ABEO) - Seeking Alpha

Mar 18, 2026
pulisher
Mar 18, 2026

Abeona Therapeutics (ABEO) One Off US$152.4m Gain Tests Bullish Profitability Narrative - simplywall.st

Mar 18, 2026
pulisher
Mar 17, 2026

Abeona targets activation of 7 QTCs for ZEVASKYN by end of 2026 as patient demand doubles - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

Stifel cuts Abeona Therapeutics stock price target on sales timing By Investing.com - Investing.com India

Mar 17, 2026
pulisher
Mar 17, 2026

Oppenheimer reiterates Abeona Therapeutics stock rating at Outperform By Investing.com - Investing.com Canada

Mar 17, 2026
pulisher
Mar 17, 2026

Stifel cuts Abeona Therapeutics stock price target on sales timing - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics Reports 2025 Financial Results, ZEVASKYN Launch Momentum, and $191.4M Cash Position - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona (ABEO) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget

Mar 17, 2026
pulisher
Mar 17, 2026

ABEO: Strong launch momentum, profitability, and expanding access position ZEVASKYN for growth - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona (ABEO) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics Q4 Earnings Call Highlights - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

ABEO: 2025 marked a profitable year with ZEVASKYN's launch, expanding access, and robust financials - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Earnings call transcript: Abeona Therapeutics Q4 2025 shows revenue growth - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics 2025 Financial Results: Annual Profit and Q4 BeatNews and Statistics - IndexBox

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics (ABEO) Reports Mixed FY Results with Revenue Beat - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics FY income from operations USD -89.448 million versus Ibes estimate USD -78.4 million - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Abeona Therapeutics (NASDAQ:ABEO) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

ABEO Exceeds Revenue Expectations with Strong Biopsy and Treatme - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

ABEONA THERAPEUTICS ($ABEO) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 17, 2026
pulisher
Mar 17, 2026

The latest financial data released by biotechnology company Abeona Therapeutics Inc shows its annual operating income recorded at -89.448 millions USD. - Bitget

Mar 17, 2026
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):